The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... by Juanjuan Li (399633)

Subjects:

Global and regional burden of PCOS from 1990 to 2019. by Jiacheng Zhang (3597089)

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DA... by Juanjuan Li (399633)

Subjects:

BAPC prediction of PCOS burden in the next 20 years. by Jiacheng Zhang (3597089)

Tim-3 deficiency enhances the levels of proinflammatory cytokines and decreases the parasite burden. by Houbao Qi (11996039)

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Sites of lymphatic filariasis prevalence estimates. by John Paul Caesar Robles delos Trinos (11859163)

Subjects:

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation... by M. S. A. Niemantsverdriet (11886431)

Age-standardized rates of PUD globally and for 21 GBD regions by SDI, 1990–2021. by Wende Hao (10315597)

Subjects:

Estimates of the prevalence of schistosome infection with respective 95% confidence intervals. by Raphäel Rakotozandrindrainy (18389756)

Subjects:

Macroeconomic burden of NMHs for the whole South American region over the period 2020–2050 across various scenarios. by Maddalena Ferranna (9969446)

Compressed sensing decoded pooled testing significantly decreases the number of tests required to identify infected samples. by Kody A. Waldstein (14002708)

Distribution of deaths caused by risk factors for four major female-specific cancers between 2000 and 2021 across 51 U.S. states. by Ze Zhang (47230)

Subjects:

Age-standardized four major female-specific cancers incidence (2017-2021) among non-Hispanic White population across 51 U.S. states. by Ze Zhang (47230)

Subjects:

Joinpoint trends in age-standardized mortality rates for the major female-specific cancers by race and ethnicity in the United States, 2000–2022. by Ze Zhang (47230)

Subjects:

Age-standardized incidence (2017–2021) and death (2018–2022) rate of four major female-related cancer among the non-Hispanic White population by state, United States. by Ze Zhang (47230)

Subjects:

Average annual age-standardized incidence (2017–2021) and death (2018–2022) rates and rate ratios with 95% confidence intervals for major female-specific cancers by race and ethnic... by Ze Zhang (47230)

Subjects:

Trends in annual age-standardized rates for six major female-specific cancers mortality (2000–2022) by race and ethnicity in the USA. by Ze Zhang (47230)

Subjects:

Trends in annual age-standardized rates for six major female-specific cancers incidence (2000-2021) by race and ethnicity in the USA. by Ze Zhang (47230)

Subjects: